RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor α on interleukin-6 production in vascular endothelial cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 81, Issue 2, 2002, Pages 141-146

  Xu, Xin ^a   Otsuki, Michio ^a   Sumitani, Satoru ^a   Saito, Hiroshi ^a   Kouhara, Haruhiko ^a   Kasayama, Soji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 6; Peroxisome proliferator activated receptor; RU486; Vascular endothelial cells

Indexed keywords

ANTIGESTAGEN; CELL NUCLEUS RECEPTOR; FENOFIBRATE; INTERLEUKIN 6; MIFEPRISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; CATTLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL NUCLEUS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERLEUKIN-6; MIFEPRISTONE; PROCETOFEN; PROTEIN TRANSPORT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

BOVINAE;

EID: 0036342229     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00055-9     Document Type: Article

References (37)

1. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
2. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
3. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients
4. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
5. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor
6. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptor α and δ
7. Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells
8. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
9. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
10. 2
11. PPARα and GR differentially down-regulate the expression of nuclear factor-κB-responsive genes in vascular endothelial cells
12. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
13. New roles for the endothelium in inflammation and immunity
14. The complexity of endothelial cells: A review
15. Endothelial-leukocyte adhesion molecules in human disease
16. RU486: A compound that gets itself talked about
17. RU486 (MIFEPRISTONE): Mechanisms of action and clinical uses
18. Antiglucocorticoid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro
19. Mechanism of action of a steroidal antiglucocorticoid in lymphoid cells
20. Association of the glucocorticoid receptor binding subunit with the 90 K nonsteroid-binding component is stabilized by both steroidal and nonsteroidal antiglucocorticoids in intact cells
21. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors
22. Progesterone receptor and the mechanism of action of progesterone antagonists
23. Receptors bound to antiprogestin from abortive complexes with hormone responsive elements
24. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant type glucocorticoid receptors
25. Determinants of subcellular distribution of the glucocorticoid receptor
26. Transcriptional activation and nuclear targeting signals of the human androgen receptor
27. Demonstration of nuclear translocation of the mineralcorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy
28. Hormone-free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90
29. Demonstration by confocal microscopy that unliganded overexpressed glucocorticoid receptors are distributed in a nonrandom manner throughout all planes of the nucleus
30. The unliganded glucocorticoid receptor is localized in the nucleus, not in the cytoplasm
31. Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers
32. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera
33. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras
34. Alteration of the glucocorticoid receptor subcellular localization by nonsteroidal compounds
35. Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor
36. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus
37. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton